Form D · Biotechnology
Sevion Therapeutics, Inc.
San Diego, CA · CIK 0001035354
Offering snapshot reported May 15, 2015 · SEC filing
- Reported sold
- $3.02M Offering amount: $10M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2015 | Initial | $3,023,746 | No comparison | 14 | SEC filing |
| Apr 9, 2010 | Initial | $11,500,000 | No comparison | 51 | SEC filing |
| May 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $191K
- Finders' fees
- $0
- Form D file number
- 021-240051
Placement agents also received warrants to purchase common stock.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Palladium Capital Advisors, LLC | 129400 | |
| Newport Coast Securities, Inc. | 16944 | |
| Laidlaw & Company (UK), Ltd. | 119037 | |
| Axiom Capital Management, Inc. | 26580 |
Source: Form D, filed May 15, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Braca | Director |
| Joel Brooks | Executive |
| Miguel A. De Los Rios | Executive |
| Richard J. Dondero | Executive |
| Christopher Forbes | Director |
| Phillip Frost | Director |
| James A. Graziano | Executive |
| Warren J. Isabelle | Director |
| Thomas C. Quick | Director |
| David Rector | Director, Executive |
| Steven Rubin | Director |
| Vaughn Smider | Director, Executive |
| Rudolf Stalder | Director |
| John E. Thompson | Director, Executive |
| Jack Van Hulst | Director, Executive |
| Harlan W. Waksal | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4045 Sorrento Valley Boulevard
San Diego, CA, 92121
San Diego, CA, 92121